As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.
New vulnerabilities in Apache Traffic Server highlight the growing security burden facing critical open-source infrastructure ...
Speaking at the ELRIG meeting at Hinxton Hall in March, Dr Seng H. Cheng set out how next-generation adeno-associated viral vector engineering has begun to move gene therapy beyond early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results